Rapid Acting insulin with pre-treatment of rHuPH20
HALO-117-406
Approved small_molecule completed
Quick answer
Rapid Acting insulin with pre-treatment of rHuPH20 for Type 1 Diabetes Mellitus is a Approved program (small_molecule) at HALOZYME THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- HALOZYME THERAPEUTICS, INC.
- Indication
- Type 1 Diabetes Mellitus
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed